Free Trial

Ameren Co. (NYSE:AEE) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Ameren logo with Utilities background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Ameren Co. (NYSE:AEE - Free Report) by 23.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,200,397 shares of the utilities provider's stock after purchasing an additional 231,373 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.45% of Ameren worth $107,003,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Woodline Partners LP acquired a new stake in Ameren in the 4th quarter valued at about $1,429,000. Vident Advisory LLC grew its position in shares of Ameren by 7.4% in the fourth quarter. Vident Advisory LLC now owns 8,455 shares of the utilities provider's stock valued at $754,000 after purchasing an additional 583 shares during the last quarter. Tidal Investments LLC grew its position in shares of Ameren by 14.3% in the fourth quarter. Tidal Investments LLC now owns 3,850 shares of the utilities provider's stock valued at $343,000 after purchasing an additional 483 shares during the last quarter. Siemens Fonds Invest GmbH purchased a new position in shares of Ameren during the 4th quarter worth approximately $10,901,000. Finally, Sherbrooke Park Advisers LLC purchased a new position in shares of Ameren during the 4th quarter worth approximately $1,061,000. 79.09% of the stock is owned by institutional investors and hedge funds.

Ameren Stock Up 0.4%

NYSE AEE traded up $0.35 during trading hours on Tuesday, hitting $96.65. The company had a trading volume of 993,631 shares, compared to its average volume of 1,564,620. Ameren Co. has a fifty-two week low of $69.39 and a fifty-two week high of $104.10. The company has a market capitalization of $26.12 billion, a price-to-earnings ratio of 21.87, a P/E/G ratio of 2.97 and a beta of 0.51. The company has a debt-to-equity ratio of 1.41, a current ratio of 0.66 and a quick ratio of 0.44. The firm's 50 day moving average is $97.92 and its 200 day moving average is $95.33.

Ameren (NYSE:AEE - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The utilities provider reported $1.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.08 by ($0.01). Ameren had a net margin of 15.51% and a return on equity of 10.34%. The firm had revenue of $2.10 billion during the quarter, compared to analyst estimates of $1.92 billion. During the same period last year, the business earned $0.98 EPS. The firm's revenue was up 15.5% compared to the same quarter last year. Sell-side analysts anticipate that Ameren Co. will post 4.93 earnings per share for the current fiscal year.

Ameren Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Tuesday, June 10th will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.94%. The ex-dividend date is Tuesday, June 10th. Ameren's dividend payout ratio (DPR) is presently 62.97%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on AEE shares. Morgan Stanley set a $102.00 target price on Ameren and gave the company an "equal weight" rating in a research note on Thursday, May 22nd. Guggenheim reissued a "neutral" rating on shares of Ameren in a report on Tuesday, April 22nd. BMO Capital Markets increased their price objective on Ameren from $106.00 to $108.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. UBS Group lifted their price objective on Ameren from $106.00 to $113.00 and gave the stock a "buy" rating in a research report on Friday, March 21st. Finally, Barclays upped their target price on shares of Ameren from $101.00 to $104.00 and gave the company an "equal weight" rating in a report on Tuesday, May 6th. Four equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $101.90.

Read Our Latest Analysis on Ameren

Insider Buying and Selling

In other news, EVP Chonda J. Nwamu sold 5,500 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $101.37, for a total transaction of $557,535.00. Following the completion of the transaction, the executive vice president now owns 43,344 shares of the company's stock, valued at approximately $4,393,781.28. The trade was a 11.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Shawn E. Schukar sold 4,743 shares of the firm's stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $103.79, for a total transaction of $492,275.97. Following the completion of the sale, the insider now owns 57,486 shares in the company, valued at $5,966,471.94. The trade was a 7.62% decrease in their position. The disclosure for this sale can be found here. 0.42% of the stock is currently owned by company insiders.

About Ameren

(Free Report)

Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.

Further Reading

Institutional Ownership by Quarter for Ameren (NYSE:AEE)

Should You Invest $1,000 in Ameren Right Now?

Before you consider Ameren, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.

While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines